Article
In vitro selection of Giardia duodenalis for Albendazole resistance identifies a β-tubulin mutation at amino acid E198K.
International journal for parasitology. Drugs and drug resistance - 1 Aug 2021
Emery-Corbin Samantha J, Su Qiao, Tichkule Swapnil, Baker Louise, Lacey Ernest, Jex Aaron R
Abstract excerpt
Benzimidazole-2-carbamate (BZ) compounds, including Albendazole (Alb), are one of just two drug classes approved to treat the gastrointestinal protist Giardia duodenalis. Benzimidazoles bind to the tubulin dimer interface overlapping the colchicine binding site (CBS) of β-tubulin, thereby inhibiting microtubule polymerisation and disrupting microtubule networks. These BZ compounds are widely used as anthelmintic,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
